DNV3837 antibiotic candidate: the Phase II trial continues in the US DNV3837 antibiotic candidate: the Phase II trial continues in the United States, despite a disrupted context due to the COVID-19 outbreak  DEINOVE (Euronext Growth Paris: ALDEI), a French biotech...